openPR Logo
Press release

Addressing the Epidemic: Insights into the Opioid Use Disorder Market Latest Study and Potential Growth | Amneal Pharmaceuticals LLC., Purdue Pharma LP

05-09-2024 08:20 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Opioid Use Disorder Market

Opioid Use Disorder Market

Coherent Market Insights has released a new research report on the Global "Opioid Use Disorder Market" for the year 2024, focusing on Size, Growth, Trends, and Dynamics, with forecasts up to 2031. This comprehensive study extensively examines market patterns, covering various aspects such as manufacturers, suppliers, market players, and consumers. The report offers insights into the factors driving the expansion of the global Opioid Use Disorder industry and is segmented based on product type, application, end-user, and region.

The research encompasses key strategic developments within the industry, including R&D, M&A, agreements, new product launches, collaborations, partnerships, joint ventures, and the regional growth of major competitors operating at both global and regional scales.

Competitive Analysis:

Understanding the present market landscape is crucial, not just for launching new products but also for sustaining existing ones amidst the constantly evolving market dynamics. This study empowers marketers to remain attuned to prevailing consumer trends and segments where they may encounter a sudden decline in market share. By conducting Market Share Analysis, marketers can discern their true competitors in the marketplace, ascertain their market position, percentage market share, and segmented revenue within the Opioid Use Disorder Market.

Click Here to Request a Sample Copy with More Details: - https://www.coherentmarketinsights.com/insight/request-sample/4597

The report further explores the key business players along with their in-depth profiling:

◘ Indivior PLC
◘ Alkermes
◘ Orexo AB
◘ Titan Pharmaceuticals Inc
◘ Teva Pharmaceutical Industries Ltd.
◘ Mallinckrodt Pharmaceuticals
◘ BioDelivery Sciences International Inc.
◘ Viatris Inc.
◘ Hikma Pharmaceuticals PLC
◘ Camurus AB
◘ Sun Pharmaceutical Industries Ltd.
◘ Amneal Pharmaceuticals LLC.
◘ Purdue Pharma LP
◘ Alvogen
◘ Faran Shimi Pharmaceutical
◘ Novartis AG
◘ Emplicure AB
◘ MODASA Pharmaceuticals Pvt. Ltd.

Market Segment Analysis:

By Drug Type: Buprenorphine, Methadone, Naltrexone, Others
By Route of Administration: Oral, Parenteral
By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmaices

Market Analysis and Insights:

The analysis of segments primarily focuses on revenue projections and forecasts concerning types and applications from 2024 to 2031. The study aims to delineate the market sizes of various segments and countries over recent years and provide forecasts for the future. This report is crafted to encompass both qualitative and quantitative aspects of the industry across all regions and countries examined. It incorporates an examination of diverse factors influencing market growth, including trends, limitations, and catalysts that shape the market positively or negatively.

Segmentation and Targeting:

Essential demographic, geographic, psychographic, and behavioral information about business segments in the Opioid Use Disorder market is targeted to aid in determining the features a company should encompass in order to fit into the business requirements. For the Consumer-based market - the study is also classified with Market Maker information in order to better understand who the clients are, their buying behavior, and patterns.

Regional Analysis, the major regions covered in the report are:

The report provides a detailed overview of the business with both qualitative and quantitative information. It provides scope and forecast of the global Opioid Use Disorder market based on various segments. Declare five major regions:

➢ North America (the United States, Canada, and Mexico)
➢ Europe (Germany, France, United Kingdom, and the Rest of Europe)
➢ Asia-Pacific (Japan, Korea, India, Southeast Asia, and Australia)
➢ South America (Brazil, Argentina, and the Rest of South America)
➢ Middle East & Africa (Saudi Arabia, UAE, Egypt, and the Rest of the Middle East & Africa)

Purchase this Complete Market Report and Get Upto 25% OFF: : https://www.coherentmarketinsights.com/insight/buy-now/4597

Key Reasons for Buying the Global Opioid Use Disorder Report:

➦ Thorough examination of the evolving competitive environment
➦ Aids in business decision-making through detailed strategic planning methods
➦ Provides forecasted data and evaluations of the Global Opioid Use Disorder Industry
➦ Facilitates comprehension of key product segments and their anticipated growth rates
➦ In-depth scrutiny of market drivers, constraints, trends, and opportunities
➦ Comprehensive regional assessment of the Global Opioid Use Disorder Industry
➦ Extensive profiling of key stakeholders within the business domain
➦ Detailed analysis of factors impacting the growth of the Global Opioid Use Disorder Industry

The report answers questions such as:

✍ What is the market size and forecast of the global Opioid Use Disorder market?
✍ What are the inhibiting factors and impact of COVID-19 shaping the global Opioid Use Disorder market during the forecast period?
✍ Which are the products/segments/applications/areas to invest in over the forecast period in the global Opioid Use Disorder market?
✍ What is the competitive strategic window for opportunities in the market?
✍ What are the technology trends and regulatory frameworks in the Opioid Use Disorder market?

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/4597

Table of Content:

1 Report Overview
1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social, and Technological) Analysis of Opioid Use Disorder Market
2 Market Trends and Competitive Landscape
3 Segmentation of Opioid Use Disorder Market by Types
4 Segmentation of Opioid Use Disorder Market by End-Users
5 Market Analysis by Major Regions
6 Product Commodity of Opioid Use Disorder Market in Major Countries
7 North America Opioid Use Disorder Landscape Analysis
8 Europe Opioid Use Disorder Landscape Analysis
9 Asia Pacific Opioid Use Disorder Landscape Analysis
10 Latin America, Middle East & Africa Opioid Use Disorder Landscape Analysis
11 Major Players Profile

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Addressing the Epidemic: Insights into the Opioid Use Disorder Market Latest Study and Potential Growth | Amneal Pharmaceuticals LLC., Purdue Pharma LP here

News-ID: 3490171 • Views:

More Releases from Coherent Market Insights

Dementia Drugs Market by Product, Growth, Size, Share, Value and Geography : Forecast and Analysis 2024 to 2031| Forest Laboratories, Inc., Eli Lilly and Company
Dementia Drugs Market by Product, Growth, Size, Share, Value and Geography : For …
Market Overview: Dementia drugs are pharmaceutical products used to treat cognitive decline associated with dementia. These include therapies for Alzheimer's disease, which accounts for 60-80% of dementia cases. Market Dynamics: The dementia drugs market is expected to grow due to the increasing prevalence of Alzheimer's disease worldwide along with high unmet need for effective treatments. According to the World Health Organization, around 55 million people globally were suffering from dementia in 2015 and
Avascular Necrosis Market Growing Worldwide by Leading Key Players, Shares, and , Regional Analysis and Forecast 2024-2031 | Solara Active Pharma Sciences Limited, Bayer AG
Avascular Necrosis Market Growing Worldwide by Leading Key Players, Shares, and …
Market Overview: Avascular necrosis (AN) is a disease that occurs due to interrupted blood supply to the bones, resulting in the death of bone tissues. It can affect any bone but is commonly found in the hip, knee, shoulder, ankle, and wrist bones. The main symptoms of AN include pain, swelling, tenderness, and restricted movement in the affected joints. Treatment options depend on the stage of the disease and may include
Epidermolysis Bullosa Market Size 2024: Revolutionizing Patient Care with Advanced Wound Management Solutions and Personalized Treatment Approaches
Epidermolysis Bullosa Market Size 2024: Revolutionizing Patient Care with Advanc …
Market Overview: Epidermolysis bullosa is a group of rare inherited connective tissue disorders that causes easy bruising of the skin and mucous membranes from minor friction or trauma. There are four major types of EB with varying severity ranging from mild skin involvement to severe whole body inflammation and blistering. Market Dynamics: The growth of the epidermolysis bullosa market is attributed to increasing R&D activities by key players for developing novel treatment options
Coronary Artery Disease Therapeutics Market to Witness A Pronounce Growth During 2024-2031 | Novartis, Pfizer, Bayer, Merck & Co, Glaxo Smith Kline
Coronary Artery Disease Therapeutics Market to Witness A Pronounce Growth During …
Market Overview: Coronary artery disease therapeutics are used for the treatment of coronary artery disease, also known as ischemic heart disease. It involves the narrowing or blockage of the coronary arteries due to plaque buildup inside the arteries. The main products used are drugs, devices, and cell therapies. Market Dynamics: The coronary artery disease therapeutics market is expected to grow owing to rising geriatric population across the globe who are more susceptible to

All 5 Releases


More Releases for Opioid

MEDICAL MARIJUANA AND THE OPIOID CRISIS
Marijuana from the Cannabis plant is classified as a psychoactive drug used for medical or recreational purposes. Although it has been used for decades, in the U.S., it is still illegal under federal law to use and possess marijuana. Get PDF Sample Brochure of this report at: https://decisionmarketreports.com/request-sample/1247622 Nevertheless, at the state level, policies regarding the medical and recreational use of Cannabis vary greatly, and in many states conflict significantly with federal
Analgesics Market Driven by Growing Opioid and Non-Opioid Medicine Sales
The application of opioids for the treatment of pain due to cancer, surgery, injury and trauma makes it a bright prospect in the augmentation of analgesics market. Along with opioid drugs, non-opioid is expected to underpin the analgesics market. Prominent companies are grappling to invest in research and development to augment non-opioid drugs through the application of innovative drug delivery approaches which will help in alleviating pain for considerably longer
Opioid Induced Constipation Treatment Market: Mu-opioid Receptor Antagonists to …
Takeda Pharmaceuticals Company, Ltd., with its approved drug Amitiza, holds a majority share in the global market for opioid induced constipation treatment. In 2014 the top three players - Takeda, Valeant Pharmaceuticals International, Ltd., and Boehringer Ingelheim – operated on a collective share of 91.8% of the global market. This is a highly consolidated market but with a large scope for the prominent players to penetrate regions other than North
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Opioid Induced Side Effects Treatment Market
Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body and are well known for the management of acute pain and cancer related pain among patients of all age group. However, opioid drugs use in
Opioid Induced Side Effects Treatment Market
Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body and are well known for the management of acute pain and cancer related pain among patients of all age group. However, opioid drugs use in